论文部分内容阅读
Melanoma is the most aggressive form of skin cancer with notorious resistance to apoptosis, which is a major barrier to the successful melanoma treatment.In 2011, FDA approved two new therapeutics for melanoma,vemurafenib and ipilimumab.